• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.

作者信息

Sarma Aruna V, Wei John T

机构信息

Department of Urology, University of Michigan, Ann Arbor, MI 48109-2800, USA.

出版信息

N Engl J Med. 2012 Jul 19;367(3):248-57. doi: 10.1056/NEJMcp1106637.

DOI:10.1056/NEJMcp1106637
PMID:22808960
Abstract
摘要

相似文献

1
Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.临床实践。良性前列腺增生与下尿路症状
N Engl J Med. 2012 Jul 19;367(3):248-57. doi: 10.1056/NEJMcp1106637.
2
Treatment of benign prostatic hyperplasia.良性前列腺增生的治疗。
Rev Assoc Med Bras (1992). 2017 Feb;63(2):95-99. doi: 10.1590/1806-9282.63.02.95.
3
[Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].[良性前列腺增生相关下尿路症状的初始评估、随访及治疗：法国泌尿外科学会下尿路症状委员会指南]
Prog Urol. 2012 Dec;22(16):977-88. doi: 10.1016/j.purol.2012.10.001. Epub 2012 Nov 6.
4
Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.新型药物治疗良性前列腺增生所致下尿路症状的比较有效性：一项系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):570-581. doi: 10.1016/j.eururo.2016.09.032. Epub 2016 Oct 4.
5
Combination therapy for non-neurogenic male lower urinary tract symptoms: 1 + 1 does not equal 2.非神经源性男性下尿路症状的联合治疗：1+1并不等于2。
Eur Urol. 2013 Aug;64(2):244-6; discussion 246-7. doi: 10.1016/j.eururo.2013.02.021. Epub 2013 Feb 19.
6
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?当前下尿路症状/BPH 的医学治疗：我们有标准吗？
Curr Opin Urol. 2014 Jan;24(1):21-8. doi: 10.1097/MOU.0000000000000007.
7
[Medical therapy of male lower urinary tract symptoms].[男性下尿路症状的医学治疗]
Urologe A. 2013 Feb;52(2):184-5. doi: 10.1007/s00120-012-3082-4.
8
Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.良性前列腺增生男性下尿路症状的医学管理。
Adv Ther. 2013 Apr;30(4):309-19. doi: 10.1007/s12325-013-0022-7. Epub 2013 Apr 12.
9
Medical therapy for benign prostatic hyperplasia: a review.良性前列腺增生的药物治疗：综述
Can J Urol. 2015 Oct;22 Suppl 1:7-17.
10
Diagnosis and medical treatment of lower urinary tract symptoms in adult men: applying specialist guidelines in clinical practice.成年男性下尿路症状的诊断和治疗：在临床实践中应用专家指南。
BJU Int. 2012 Sep;110(5):710-8. doi: 10.1111/j.1464-410X.2011.10808.x. Epub 2011 Dec 7.

引用本文的文献

1
Poor sleep patterns are associated with the prevalence of benign prostatic hyperplasia in US aged 40 and older: A cross-sectional study based on NHANES.睡眠模式不佳与美国40岁及以上人群良性前列腺增生的患病率相关：一项基于美国国家健康和营养检查调查的横断面研究。
PLoS One. 2025 Feb 25;20(2):e0319434. doi: 10.1371/journal.pone.0319434. eCollection 2025.
2
Beyond the Comfort Zone: Strenuous Sports as a Preventive Tactic Against Benign Prostatic Hyperplasia.走出舒适区：剧烈运动作为预防良性前列腺增生的一种策略
Am J Mens Health. 2025 Jan-Feb;19(1):15579883241311209. doi: 10.1177/15579883241311209.
3
Effect of Proanthocyanidins from Grape Seed Extract on Benign Prostatic Hyperplasia.
葡萄籽提取物中原花青素对良性前列腺增生的影响。
Nutrients. 2024 Dec 28;17(1):73. doi: 10.3390/nu17010073.
4
The Influence of Dietary Habits on Male Lower Urinary Tract Symptoms: Differential Influence of Water Intake on Voiding Symptoms and Storage Symptoms.饮食习惯对男性下尿路症状的影响：水分摄入对排尿症状和储尿症状的不同影响。
World J Mens Health. 2025 Jul;43(3):647-660. doi: 10.5534/wjmh.230361. Epub 2024 Nov 20.
5
Public Views on Managing Benign Prostatic Hyperplasia-Related Voiding Dysfunction: Potential Applications of Digital Therapeutic.公众对良性前列腺增生相关排尿功能障碍管理的看法：数字疗法的潜在应用
Int Neurourol J. 2024 Nov;28(Suppl 2):S90-96. doi: 10.5213/inj.2448398.199. Epub 2024 Nov 30.
6
A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study.良性前列腺增生患者外科治疗医院间差异的真实世界证据研究：REVALURO研究
Int Urol Nephrol. 2025 Mar;57(3):775-784. doi: 10.1007/s11255-024-04239-7. Epub 2024 Oct 29.
7
NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells.鼻型锌指蛋白通过抑制前列腺上皮细胞的增殖、氧化应激和炎症反应参与良性前列腺增生。
Transl Androl Urol. 2024 Sep 30;13(9):2055-2069. doi: 10.21037/tau-24-209. Epub 2024 Sep 24.
8
Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats.壮瑶健肾丸可改善睾丸酮诱导的大鼠良性前列腺增生。
J Tradit Chin Med. 2024 Aug;44(4):694-702. doi: 10.19852/j.cnki.jtcm.20240627.001.
9
Risk factors associated with the severity of overactive bladder among Syrian patients with type 2 diabetes.叙利亚2型糖尿病患者膀胱过度活动症严重程度的相关危险因素。
Sci Rep. 2024 Jul 17;14(1):16547. doi: 10.1038/s41598-024-67326-w.
10
The relationship between complete blood cell count-derived inflammatory biomarkers and benign prostatic hyperplasia in middle-aged and elderly individuals in the United States: Evidence from NHANES 2001-2008.美国中老年人群全血细胞计数衍生炎症生物标志物与良性前列腺增生的关系：来自 NHANES 2001-2008 的证据。
PLoS One. 2024 Jul 9;19(7):e0306860. doi: 10.1371/journal.pone.0306860. eCollection 2024.